comparemela.com

Latest Breaking News On - Soo romanoff - Page 2 : comparemela.com

Edison issues initiation on Cereno Scientific (CRNO B): Differentiated approach in CVD with potential

Edison issues initiation on Cereno Scientific (CRNO B): Differentiated approach in CVD with potential
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomSoo romanoffArron aatkarJitisha malhotraJyoti prakashNews serviceFinancial conduct authorityEdison investment researchEdison investment research limitedCereno scientific

Volition to Share Nu Q® NETs Strategy Update at Upcoming Webinar

/PRNewswire/ VolitionRx Limited (NYSE American: VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hosted by Edison.

United statesCity ofUnited kingdomSoo romanoffLouise batchelor debra daglishAndrew retterVolitionrx limitedEdison groupHealthcare at edison groupExchange commissionSecurities exchangeGael forterreChief commercial officerUnited kingdom based intensive care consultantMedical consultantManaging director

Edison issues update on e-therapeutics (ETX): More to come in RNAi therapy discovery -November 13, 2023 at 04:07 am EST

Edison Investment Research Limited Edison issues update on e-therapeutics : More to come in RNAi therapy discovery 13-Nov-2023 / 09:05 GMT/BST The issuer is solely responsible.

New south walesNew yorkUnited statesCity ofUnited kingdomNew zealand generalNew zealandNidhi singhArron aatkarSoo romanoffFinancial conduct authorityFinancial conduct

VolitionRx to unveil new cancer detection method insights at upcoming webinar

VolitionRx (NYSE-A:VNRX) Limited has announced that it is participating in a webinar hosted by Edison Group, to expound new cancer data to be presented.

Soo romanoffJake micallefAndrew retterEdison groupEuropean society for medical oncologyEuropean societyGael forterreUnited kingdom based

OSE Immunotherapeutics (OSE): Re-initiation - Milestones anticipated throughout FY23

DJ OSE Immunotherapeutics (OSE): Re-initiation - Milestones anticipated throughout FY23 Edison Investment Research Limited OSE Immunotherapeutics (OSE): Re-initiation - Milestones anticipated throughout

New south walesSouth africaCity ofUnited kingdomTel avivNoord hollandNew yorkUnited statesSoo romanoffGewinn nurFinancial conduct authorityEdison investment research limitedNews serviceFinancial conductDow jones newswires

vimarsana © 2020. All Rights Reserved.